Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?

BACKGROUND: Recent studies showed that the non-adherence to the pharmacological therapy of patients affected by BPH-associated LUTS increased the risk of clinical progression of BPH. We examined the patients adherence to pharmacological therapy and its clinical consequences in men with BPH-associate...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Urol
Asıl Yazarlar: Cindolo, Luca, Pirozzi, Luisella, Sountoulides, Petros, Fanizza, Caterina, Romero, Marilena, Castellan, Pietro, Antonelli, Alessandro, Simeone, Claudio, Tubaro, Andrea, de Nunzio, Cosimo, Schips, Luigi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4578263/
https://ncbi.nlm.nih.gov/pubmed/26391357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-015-0090-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller